ULCEROGENIC AND ANTIULCEROGENIC EFFECTS OF A NEW ANTIINFLAMMATORY DRUG, THE GAMMA-LACTONE-N-ETHYL DERIVATIVE OF 6-[1S-(3S,4-DIHYDRO-8-HYDROXY-1H-2-BENZO-PYRAN-1-ONE-3-YL)-3-METHYLBUTYLAMINO]-4S,5S-DIHYDROXY-6-OXO-3S- AMMONIOHEXANOATE, ON GASTROINTESTINAL-TRACT IN RATS

被引：0

作者：

URUSHIDANI, T ^{[1
]}

KASUYA, Y ^{[1
]}

YANO, S ^{[1
]}

机构：

[1] CHIBA UNIV,FAC PHARMACEUT SCI,DEPT DRUG EVALUATION & TOXICOL SCI,CHIBA,JAPAN

来源：

ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1986年 / 36-2卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1383 / 1390

页数：8

共 50 条

[31] Crystal structure of (1S,3S,6S,7S,8S,9S)-7,9-diacetoxy-6-(4-methoxybenzyl)-3-[N-methyl-N-(4-methylphenyl)sulfonylamino]-5-azatricyclo-[6.3.1.01,5]dodecan-4-one-methanol (1/0.25), C31H38N2O8S • 1/4(CH3OH)
Bavoux, C
Perrin, M
Ousmer, M
Braun, NA
Ciufolini, MA
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2001, 216 (03): : 361 - 362
[32] Crystal structure of μ3-bromo-2:3:4κ3Br-oxo-1κO-tri-μ3-sulfido-1:2:3κ3S;1:2:4κ3S;-1:3:4κ3S-tris(triphenylphosphine)-2κP;3κP;4κP;-tri-copper molybdenum-quinoline (2:1), {MoOS3Cu3Br[P(C6H5)3]3} • 0.5C9H7N
Jin, QH
Zheng, HG
Yu, KB
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2002, 217 (04): : 612 - 614
[33] Cardioprotective effects of (2S,3R,4S)-N′-benzyl-N"-cyano-N-(3,4-dihydro-2-dimethoxymethyl-3-hydroxy-2-methyl-6-nitro-2H-benzopyran-4-yl)-guanidine (KR-31372) in rats and dogs
Lee, BH
Seo, HW
Yoo, SE
PHARMACOLOGY, 2004, 70 (02) : 74 - 82
[34] 3-(4-Bromophenyl)-3-(4-hydroxy-6-oxo-1,6-dihydropyrimidin-5-yl)-N-[(S)-1-phenylethyl]propanamide
Peng, Ju-Hua
Hao, Wen-Juan
Tu, Shu-Jiang
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : 0489 - U1522
[35] Crystal structure of S-ethyl (3S,4R,5S,6S)-5-carbothioate-3,4-dimethyl-6-phenyltetrahydropyridin-2(1H)-one, C16H21NO2S
Tinant, B
Declercq, JP
Jnoff, E
Ghosez, L
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 1999, 214 (03): : 321 - 322
[36] Crystal structure of (1S,3S,6S,7S,8S,9R)-7-acetoxy-9-hydroxy 6-(4-methoxybenzyl)-3-[N-methyl-N-(4-methylphenyl)sulfonylamino]-5-azatricyclo[6.3.1.01.5]dodecan-4-one, C29H36N2O7S
Ousmer, M
Braun, NA
Ciufolini, MA
Perrin, M
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2000, 215 (04): : 597 - 599
[37] The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents
Hutson, P. H.
Finger, E. N.
Magliaro, B. C.
Smith, S. M.
Converso, A.
Sanderson, P. E.
Mullins, D.
Hyde, L. A.
Eschle, B. K.
Turnbull, Z.
Sloan, H.
Guzzi, M.
Zhang, X.
Wang, A.
Rindgen, D.
Mazzola, R.
Vivian, J. A.
Eddins, D.
Uslaner, J. M.
Bednar, R.
Gambone, C.
Le-Mair, W.
Marino, M. J.
Sachs, N.
Xu, G.
Parmentier-Batteur, S.
NEUROPHARMACOLOGY, 2011, 61 (04) : 665 - 676
[38] Crystal structure of (1′R,2′S,4′R,6′S)-4,6-dihydroxy-1′,8′,8′-trimethyl-3-(3-methylbutanoyl)-4′,8′,6′,1′,7,2′-hexahydro-1H-4′,6′-methanoxanthene-8-carbaldehyde, C23H30O5
Huang, Nian
Zhou, Lang
Zhang, Yin-Ju
Chen, Fa-Ju
Li, Qi-Ji
Zhao, Neng-Wu
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (05): : 933 - 935
[39] Stereoselective synthesis of (2R,3S,4S,5R)-trans-3,4-dihydroxy-5-(4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran and (2R,3S,4S,5R)-trans-5-ethynyl-2(4-fluorophenoxymethyl)-3,4-O-isopropylidene tetrahydrofuran from mannose diacetonide
Sharma, GVM
Punna, S
Hymavathi, L
Reddy, NY
Krishna, PR
Chorghade, MS
Ley, SV
TETRAHEDRON-ASYMMETRY, 2005, 16 (06) : 1135 - 1140
[40] (1R, 2S, 4S, 4aS, 8S, 8aS)-4-Hydroxy-8,8a-dimethyl-10-oxo-2,3,4,7,8,8a-hexahydro1H-4a,1-(epoxymethano)naphthalen-2-yl acetate
Selaiemia-Ferdjani, Ouassila
Bidjou-Haiour, Chahra
Planchat, Aurelien
Pipelier, Muriel
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O938 - +

← 1 2 3 4 5 →